Our research projects

Using steroids can increase the risk of developing a specific type of diabetes called steroid diabetes. It can also lead to higher blood sugar levels in people with other types of diabetes. Dr Katharine Lazarus will explore if a type 2 diabetes medication, called semaglutide, could help to lower this risk and lower blood sugar levels. This study could pave the way for a safer steroid use for people with or at risk of diabetes.

Type 1 diabetes develops when the immune system attacks and destroys insulin-making beta cells. Dr Matthew Johnson and his team will study a rare type of diabetes that could help us better understand why the immune system turns on beta cells, and how this process may differ between people. This could pave the way towards new treatments that protect the pancreas from harm in people with or at risk of type 1 diabetes.

Tiny variations in our genes can affect insulin receptors, which sit on the surface of our cells and allow insulin to enter. Problems with insulin receptors affect how our body responds to insulin and can cause severe insulin resistance. Professor Semple and his student want to find out how thousands of different genetic variations affect how the insulin receptor works, and which variations contribute to insulin resistance. They hope this will make it easier to diagnose people with rare types of diabetes and help them learn more about how insulin works in all types of diabetes, paving the way to new insulins or ways of making insulin work better. 

Women who’ve had gestational diabetes have a 10-fold higher risk of later developing type 2 diabetes. Dr Nerys Astbury and her PhD student will develop a ‘calculator’ to predict which women have the highest risk. They’ll then create a new, tailored treatment that aims to help women reduce their risk. This research could help to prevent more cases of type 2 in women who’ve had gestational diabetes, giving women healthier futures.

Bone health and blood sugar levels are closely linked, with each affecting the other. Dr Karla Suchacki will investigate if weak bones make it harder for the body to manage blood sugar levels by studying how rats with osteoporosis process glucose (sugar). This could help explain how weak bones increase type 2 diabetes risk and lead to better tools to predict and prevent type 2 for people with bone conditions.  

We know that a person’s genetic makeup is important in type 2 diabetes but we don’t know exactly how they’re linked. Dr Jennings is going to study genes related to beta cell and pancreas development and the 3D switches that control them. This will give us a better understanding of why type 2 diabetes develops, which could lead to new therapies to prevent and treat it. 

Researchers are building AI-powered tools that can identify people most at risk of diabetes complications before they develop. Dr Rebecca Thomas is exploring how people with diabetes feel towards AI being used in this way, and receiving results about their future complications risk. This will inform recommendations on how to communicate AI-driven risk predictions in a way that builds trust and understanding, supporting both physical health and emotional well-being.

Some people develop type 1 diabetes very quickly, but in others, the immune attack that causes type 1 diabetes progresses slowly. Professor Kathleen Gillespie and her PhD student will look for genetic differences between these groups of people to find out why this is. In the future, this could lead to life-changing treatments to delay or prevent type 1 diabetes.

Having diabetes can lead to damaged blood vessels in the retina at the back of the eye, caused by high blood sugar levels. This can lead to vision problems and sight loss. Dr Judith Lechner wants to find out if a protective protein can be used to repair and reduce this damage, and potentially be used as a new treatment option in the future.

Women with type 1 or type 2 diabetes are at a higher risk of stillbirth and premature birth. Dr Sharon Mackin and her team will analyse national data in Scotland to identify the causes and risk factors for these outcomes. This could lead to better care and decision-making around delivery timing, so that more mothers with diabetes experience a healthy pregnancy and give birth to healthy babies.